Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA9 | Q16790 | 4/20 | 0.39 |
| ▸ | F9 | P00740 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.36 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17945057 | 0.97 | ALDH1A1 (0.40) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL17932229 | 0.96 | ALDH1A1 (0.39) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL22178895 | 0.95 | F9 (0.39) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL20650671 | 0.94 | ALDH1A1 (0.44) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL17945521 | 0.93 | ALOX5 (0.46) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21687004 | 0.93 | ALDH1A1 (0.41) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL24174606 | 0.93 | ALDH1A1 (0.42) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21020080 | 0.92 | F9 (0.39) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL23266746 | 0.92 | F9 (0.39) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL17945064 | 0.92 | CA12 (0.36) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
| US-10629825-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-21 | — | — | US | disclosed |
| US-20170133590-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-05-11 | — | — | US | disclosed |
| US-20170133590-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | OLA1, TAS2R19, TMEM109 | ALDH1A1 541/4885MAPT 2477/4885HPGD 4701/4885 |
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | EMC2, NFE2L2, AOC2 | ALDH1A1 1970/4885MAPT 2667/4885HPGD 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.